JP2007535910A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2007535910A5 JP2007535910A5 JP2006544559A JP2006544559A JP2007535910A5 JP 2007535910 A5 JP2007535910 A5 JP 2007535910A5 JP 2006544559 A JP2006544559 A JP 2006544559A JP 2006544559 A JP2006544559 A JP 2006544559A JP 2007535910 A5 JP2007535910 A5 JP 2007535910A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- derivative
- polypeptide
- analogue
- analog
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 108090000765 processed proteins & peptides Proteins 0.000 claims 22
- 229920001184 polypeptide Polymers 0.000 claims 21
- 102000004196 processed proteins & peptides Human genes 0.000 claims 21
- 150000001413 amino acids Chemical class 0.000 claims 8
- 229940024606 amino acid Drugs 0.000 claims 7
- 235000001014 amino acid Nutrition 0.000 claims 7
- 208000036142 Viral infection Diseases 0.000 claims 4
- 239000008194 pharmaceutical composition Substances 0.000 claims 4
- 230000009385 viral infection Effects 0.000 claims 4
- FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 claims 3
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 claims 3
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 claims 3
- 108091028043 Nucleic acid sequence Proteins 0.000 claims 3
- 239000003814 drug Substances 0.000 claims 3
- 150000007523 nucleic acids Chemical group 0.000 claims 3
- 108010043958 Peptoids Proteins 0.000 claims 2
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 claims 2
- 238000004519 manufacturing process Methods 0.000 claims 2
- 125000000430 tryptophan group Chemical group [H]N([H])C(C(=O)O*)C([H])([H])C1=C([H])N([H])C2=C([H])C([H])=C([H])C([H])=C12 0.000 claims 2
- 101150037123 APOE gene Proteins 0.000 claims 1
- 239000004475 Arginine Substances 0.000 claims 1
- DCXYFEDJOCDNAF-UHFFFAOYSA-N Asparagine Natural products OC(=O)C(N)CC(N)=O DCXYFEDJOCDNAF-UHFFFAOYSA-N 0.000 claims 1
- 101100216294 Danio rerio apoeb gene Proteins 0.000 claims 1
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 claims 1
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 claims 1
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 claims 1
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 claims 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 claims 1
- 239000004472 Lysine Substances 0.000 claims 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 claims 1
- 229960001230 asparagine Drugs 0.000 claims 1
- 235000009582 asparagine Nutrition 0.000 claims 1
- 125000000613 asparagine group Chemical group N[C@@H](CC(N)=O)C(=O)* 0.000 claims 1
- 230000004071 biological effect Effects 0.000 claims 1
- 125000004432 carbon atom Chemical group C* 0.000 claims 1
- 235000018417 cysteine Nutrition 0.000 claims 1
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 claims 1
- 229940079593 drug Drugs 0.000 claims 1
- 230000002708 enhancing effect Effects 0.000 claims 1
- ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 claims 1
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 claims 1
- 229960000310 isoleucine Drugs 0.000 claims 1
- AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 claims 1
- 229930182817 methionine Natural products 0.000 claims 1
- 229910052757 nitrogen Inorganic materials 0.000 claims 1
- 125000004433 nitrogen atom Chemical group N* 0.000 claims 1
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 claims 1
- 238000006467 substitution reaction Methods 0.000 claims 1
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 claims 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0329254.7A GB0329254D0 (en) | 2003-12-17 | 2003-12-17 | Treatment of viral infections |
| PCT/GB2004/005360 WO2005058959A2 (en) | 2003-12-17 | 2004-12-17 | Treatment of viral infections |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2012020504A Division JP2012115277A (ja) | 2003-12-17 | 2012-02-02 | ウイルス感染の治療 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2007535910A JP2007535910A (ja) | 2007-12-13 |
| JP2007535910A5 true JP2007535910A5 (enExample) | 2008-02-07 |
Family
ID=30471239
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2006544559A Pending JP2007535910A (ja) | 2003-12-17 | 2004-12-17 | ウイルス感染の治療 |
| JP2012020504A Pending JP2012115277A (ja) | 2003-12-17 | 2012-02-02 | ウイルス感染の治療 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2012020504A Pending JP2012115277A (ja) | 2003-12-17 | 2012-02-02 | ウイルス感染の治療 |
Country Status (11)
| Country | Link |
|---|---|
| US (3) | US7691382B2 (enExample) |
| EP (2) | EP1709075B9 (enExample) |
| JP (2) | JP2007535910A (enExample) |
| CN (2) | CN102336815A (enExample) |
| AU (1) | AU2004299343B8 (enExample) |
| CA (1) | CA2548585A1 (enExample) |
| DK (1) | DK1709075T3 (enExample) |
| ES (1) | ES2389078T3 (enExample) |
| GB (1) | GB0329254D0 (enExample) |
| PL (1) | PL1709075T3 (enExample) |
| WO (1) | WO2005058959A2 (enExample) |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0329254D0 (en) * | 2003-12-17 | 2004-01-21 | Univ Manchester | Treatment of viral infections |
| GB0329958D0 (en) * | 2003-12-24 | 2004-01-28 | Univ Manchester | Treatment of viral infections |
| GB0404374D0 (en) * | 2004-02-27 | 2004-03-31 | Univ Manchester | Treatment of bacterial infections |
| GB0513096D0 (en) * | 2005-06-28 | 2005-08-03 | Strathclyde | Treatment of microbial infections |
| EP1937815B1 (en) | 2005-09-13 | 2015-05-13 | National Research Council of Canada | Methods and compositions for modulating tumor cell activity |
| PL2085774T3 (pl) * | 2008-02-01 | 2018-08-31 | Kraft Foods R & D, Inc. | Sposób określania konsystencji materiału spożywczego |
| WO2009102715A2 (en) * | 2008-02-11 | 2009-08-20 | Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College | Peptide therapy for ocular herpes infections |
| JP5553336B2 (ja) * | 2008-02-14 | 2014-07-16 | 国立大学法人京都工芸繊維大学 | ペプチド、当該ペプチドの用途及び生産方法並びに当該ペプチドが固定化された固相及びその生産方法 |
| PT2504363T (pt) | 2009-11-24 | 2019-08-02 | Nat Res Council Canada | Anticorpos anticlusterina e fragmentos de ligação ao antigénio e a sua utilização para reduzir o volume de um tumor |
| US20120053128A1 (en) * | 2010-08-26 | 2012-03-01 | Xavier University | Method of inhibiting angiogenesis |
| US9234026B2 (en) | 2011-07-21 | 2016-01-12 | University of Pittsburgh—of the Commonwealth System of Higher Education | Apolipoprotein E polypeptides and their use |
| MX2014010164A (es) | 2012-02-22 | 2014-11-25 | Alethia Biotherapeutics Inc | Co-uso de un inhibidor de clusterina con un inhibidor de egfr para tratar cancer. |
| US9636299B2 (en) | 2012-03-29 | 2017-05-02 | Xavier University Of Louisiana | Method for treating diabetic retinopathy |
| CA2962945A1 (en) | 2014-10-01 | 2016-04-07 | Plant Health Care, Inc. | Elicitor peptides having disrupted hypersensitive response box and use thereof |
| US20170298100A1 (en) * | 2014-10-01 | 2017-10-19 | Cascadia Life Sciences Llc | Anti-viral peptides |
| PL3201341T3 (pl) | 2014-10-01 | 2025-09-01 | Plant Health Care, Inc. | Peptydy wywołujące reakcję nadwrażliwości i ich zastosowanie |
| BR112018069945A2 (pt) | 2016-04-06 | 2019-02-05 | Plant Health Care, Inc. | micróbios benéficos para distribuição de peptídeos ou proteínas efetoras e uso dos mesmos |
| BR112018070141A2 (pt) | 2016-04-06 | 2019-02-12 | Plant Health Care, Inc. | resposta hipersensitiva de peptídeos derivados de eliciador e uso dos mesmos |
| JP7745323B2 (ja) * | 2019-04-30 | 2025-09-29 | マックスウェル バイオサイエンシーズ,インコーポレイテツド | ハロゲン化抗菌ペプトイド |
| CN116813712B (zh) * | 2023-06-16 | 2024-03-29 | 东北农业大学 | 一种富含Trp的α-螺旋结构抗菌肽W33及其制备方法和应用 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5473039A (en) * | 1989-08-18 | 1995-12-05 | The Scripps Research Institute | Polypeptide analogs of apolipoprotein E, diagnostic systems and methods using the analogs |
| WO1993000443A1 (en) * | 1991-06-26 | 1993-01-07 | Bio-Technology General Corp. | Purification of recombinant apolipoprotein e from bacteria |
| US5344822A (en) | 1992-08-12 | 1994-09-06 | The Rogosin Institute | Methods useful in endotoxin prophylaxis and therapy |
| JP2001518449A (ja) * | 1997-09-30 | 2001-10-16 | デューク・ユニバーシティー | アポリポタンパク質e/成長因子複合体およびその使用法 |
| US7205280B2 (en) * | 1998-03-11 | 2007-04-17 | Cognosci, Inc. | Methods of suppressing microglial activation |
| GB0200757D0 (en) * | 2002-01-15 | 2002-02-27 | Univ Manchester | Diagnostic methods |
| GB0329254D0 (en) * | 2003-12-17 | 2004-01-21 | Univ Manchester | Treatment of viral infections |
-
2003
- 2003-12-17 GB GBGB0329254.7A patent/GB0329254D0/en not_active Ceased
-
2004
- 2004-12-17 JP JP2006544559A patent/JP2007535910A/ja active Pending
- 2004-12-17 ES ES04806160T patent/ES2389078T3/es not_active Expired - Lifetime
- 2004-12-17 EP EP04806160A patent/EP1709075B9/en not_active Expired - Lifetime
- 2004-12-17 DK DK04806160.0T patent/DK1709075T3/da active
- 2004-12-17 AU AU2004299343A patent/AU2004299343B8/en not_active Ceased
- 2004-12-17 WO PCT/GB2004/005360 patent/WO2005058959A2/en not_active Ceased
- 2004-12-17 CA CA002548585A patent/CA2548585A1/en not_active Abandoned
- 2004-12-17 EP EP10010764A patent/EP2277911A1/en not_active Withdrawn
- 2004-12-17 US US10/580,761 patent/US7691382B2/en not_active Expired - Lifetime
- 2004-12-17 CN CN2011102495236A patent/CN102336815A/zh active Pending
- 2004-12-17 CN CN2004800379084A patent/CN1894281B/zh not_active Expired - Fee Related
- 2004-12-17 PL PL04806160T patent/PL1709075T3/pl unknown
-
2010
- 2010-02-09 US US12/702,919 patent/US20100221273A1/en not_active Abandoned
-
2012
- 2012-02-02 JP JP2012020504A patent/JP2012115277A/ja active Pending
- 2012-07-16 US US13/550,029 patent/US20130150288A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2007535910A5 (enExample) | ||
| JP2012115277A5 (enExample) | ||
| JP2004536077A5 (enExample) | ||
| JP5695318B2 (ja) | 組織傷害の修復におけるストロマ細胞由来因子1のプロテアーゼ耐性変異体 | |
| JP2018171063A5 (enExample) | ||
| JP2012518035A5 (enExample) | ||
| JP2008511323A5 (enExample) | ||
| JP2013515057A5 (enExample) | ||
| JP2013515055A5 (enExample) | ||
| JP2013155195A5 (enExample) | ||
| JP2010524971A5 (enExample) | ||
| JP2008536483A5 (enExample) | ||
| HUT70459A (en) | Analogs of pth | |
| JP2013500990A5 (enExample) | ||
| JP2010516688A (ja) | 抗菌ペプチド | |
| HRP20110242T1 (hr) | Formulacija s fuzijskim proteinom glp-1-fc | |
| JP2010515686A5 (enExample) | ||
| RU2011134596A (ru) | Аналоги оксинтомодулина | |
| JP2014519852A5 (enExample) | ||
| JP2008507298A5 (enExample) | ||
| JP2011518179A5 (enExample) | ||
| JPWO2019156137A5 (enExample) | ||
| JP2010536714A5 (enExample) | ||
| JP2006506942A5 (enExample) | ||
| JP2015504052A5 (enExample) |